This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by EPSTEIN, S. E. Articles by SKELTON, C. L. Search for Related Content PubMed PubMed Citation Articles by EPSTEIN, S. E. Articles by SKELTON, C. L.

(Circulation. 1971;43:437.)
© 1971 American Heart Association, Inc.

---

Adenyl Cyclase and Cyclic AMP

Biochemical Links in the Regulation of Myocardial Contractility

STEPHEN E. EPSTEIN M.D.¹; GERALD S. LEVEY M.D.²; C. LYNN SKELTON M.D.¹

¹ From the Cardiology Branch, National Heart and Lung Institute, Bethesda, Maryland 20014 and the Department of Medicine, University of Miami School of Medicine, Miami, Florida.
² From the Cardiology Branch, National Heart and Lung Institute, Bethesda, Maryland 20014 and the Department of Medicine, University of Miami School of Medicine, Miami, Florida.; Department of Medicine, University of Miami School of Medicine, Miami, Florida.

The actions of many hormones may be related to their capacity to increase adenyl cyclase activity in their target organs. The evidence indicating that catecholamines and glucagon augment myocardial contractility by enhancing the activity of myocardial adenyl cyclase is summarized. Furthermore, data are presented suggesting that the inotropic actions of epinephrine and glucagon ultimately may be due to an increase in sarcotubular calcium stores, an effect that appears to be related to activation of an adenyl cyclase pool localized in the sarcoplasmic reticulum. Other hormones that may alter contractility through actions on the adenyl cyclase-cyclic AMP system are thyroid hormone, histamine, prostaglandin, and acetylcholine. Chronic cardiac decompensation in both the experimental animal and in man diminishes the effectiveness of glucagon as an inotropic agent and interferes with the mechanisms by which glucagon acts to enhance the activity of myocardial adenyl cyclase, changes that may be causally interrelated. Although an understanding of the adenyl cyclase system would seem to be extremely important for an understanding of the basic mechanisms responsible for modulating the intensity of the contractile state of the heart, further investigations are necessary for complete validation of this hypothesis.

Key Words: Thyroid hormone • Sarcoplasmic reticulum • Glucagon • Dibutyryl cyclic AMP • Norepinephrine • Cardiac failure

Submitted on November 20, 1970
Accepted on December 1, 1970

This article has been cited by other articles:

				I. Harary, F. Hoover, and B. Farley Catecholamine and Dibutyryl Cyclic AMP Effects on Myosin Adenosine Triphosphatase in Cultured Rat Heart Cells Science, September 14, 1973; 181(4104): 1061 - 1063. [Abstract] [PDF]

				E. W. Sutherland Studies on the Mechanism of Hormone Action Science, August 4, 1972; 177(4047): 401 - 408. [PDF]